Sundrug CoSDGCF 79 ROC (Joel Greenblatt) % is 19.39% as of Mar. 2026, which is 61% below its 10-year median of 50.05. GuruFocus rates SDGCF with a GF Score™ of 79/100 and a GF Value™ of $34.88. The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Sundrug Co ranks better than 67.96% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sundrug Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 19.39%.
The historical rank and industry rank for Sundrug Co's ROC (Joel Greenblatt) % or its related term are showing as below:
SDGCF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.32 Med: 50.05 Max: 69.47
Current: 23.32
During the past 13 years, Sundrug Co's highest ROC (Joel Greenblatt) % was 69.47%. The lowest was 23.32%. And the median was 50.05%.
SDGCF's ROC (Joel Greenblatt) % is ranked better than 67.96% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 12.485
vs SDGCF: 23.32
Sundrug Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -15.10% per year.
Sundrug Co (OTCPK:SDGCF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Sundrug Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Sundrug Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sundrug Co's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 19.39% mean?
Sundrug Co (SDGCF) has a ROC (Joel Greenblatt) % of 19.39% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sundrug Co and its competitors. This is 61% below median its historical median of 50.05. Over the past decade, Sundrug Co's ROC (Joel Greenblatt) % has ranged from 23.32 to 69.47. According to the industry distribution chart, Sundrug Co ranks #214 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 32%.
Is Sundrug Co's ROC (Joel Greenblatt) % too high?
Sundrug Co's current ROC (Joel Greenblatt) % of 19.39% is 61% below median its 10-year median of 50.05. Over the past 10 years, this metric has ranged from a low of 23.32 to a high of 69.47. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Sundrug Co's value of 19.39% is 55.3% above this industry median. Based on the distribution chart, Sundrug Co ranks #214 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sundrug Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #214 out of 668 companies for ROC (Joel Greenblatt) %. This puts Sundrug Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.49. Sundrug Co's value of 19.39% is 55.3% above this benchmark. Historically, Sundrug Co's own ROC (Joel Greenblatt) % has ranged from 23.32 to 69.47 over the past decade. While the company's 10-year median is 50.05 vs. the industry median of 12.49, Sundrug Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current ROC (Joel Greenblatt) % of 19.39% is 55.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current ROC (Joel Greenblatt) % is 19.39%, which is 61% below median its own 10-year median of 50.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current ROC (Joel Greenblatt) % of 19.39%. The stock's GF Value™ is $34.88, compared to a current price of $28.18 — trading 19.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 19.39%, which is 61% below median its 10-year median of 50.05 and 55.3% above the Healthcare Providers & Services industry median of 12.49. Sundrug Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current ROC (Joel Greenblatt) % is 19.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.2% below its estimated GF Value™ of $34.88.
Key valuation signals for SDGCF:
ROC (Joel Greenblatt) %: 19.39% (61% below median its 10-year median of 50.05)
GF Value™: $34.88 vs. price of $28.18 (19.2% below fair value)
Industry Position: 55.3% above the Healthcare Providers & Services median (#214 of 668)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
79GF Score
Get the complete analysis for SDGCF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
